Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Oxaliplatin × Clear all

NCT00305786 2016-12-15

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01243775 2015-08-17

BELOXAN

Phase 2 Completed

33 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT00240097 2014-11-27

Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)

Phase 2 Completed

30 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT00145418 2014-06-30

Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer

Phase 2 Terminated

15 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT00406302 2014-04-29

Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00004126 2013-02-11

Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00251524 2012-05-11

A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT01497041 2011-12-22

A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT01222312 2011-11-29

Taxelox

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00356122 2011-10-17

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

53 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00452881 2010-10-25

Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00453115 2010-10-25

Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00271271 2009-12-07

GON

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00923637 2009-06-18

Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00217282 2008-05-22

Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00238849 2005-10-14

Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung